Cargando…
p62 promotes proliferation, apoptosis-resistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis
Prostate cancer poses a public health threat to hundreds of people around the world. p62 has been identified as a tumor suppressor, however, the mechanism by which p62 promotes prostate cancer remains poorly understood. The present study aimed to investigate whether p62 promotes proliferation, apopt...
Autores principales: | Jiang, Ganggang, Liang, Xue, Huang, Yiqiao, Lan, Ziquan, Zhang, Zhiming, Su, Zhengming, Fang, Zhiyuan, Lai, Yuxiong, Yao, Wenxia, Liu, Ting, Hu, La, Wang, Fen, Huang, Hai, Liu, Leyuan, Jiang, Xianhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107779/ https://www.ncbi.nlm.nih.gov/pubmed/32323805 http://dx.doi.org/10.3892/or.2020.7527 |
Ejemplares similares
-
Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer
por: Huang, Yiqiao, et al.
Publicado: (2018) -
Molecular and cellular mechanisms of castration resistant prostate cancer
por: Huang, Yiqiao, et al.
Publicado: (2018) -
MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma
por: Su, Zhengming, et al.
Publicado: (2020) -
Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway
por: Guo, Yingying, et al.
Publicado: (2022) -
p62 promotes bladder cancer cell growth by activating KEAP1/NRF2‐dependent antioxidative response
por: Li, Tao, et al.
Publicado: (2020)